150 related articles for article (PubMed ID: 37498068)
1. TRIM31 promotes the progression of oral squamous cell carcinoma through upregulating AKT phosphorylation and subsequent cellular glycolysis.
Sang SQ; Zhao YJ; Wang M; Zhong XQ; Yang ZC; Lu MM
Neoplasma; 2023 Jun; 70(3):402-415. PubMed ID: 37498068
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of PER2 Promotes Tumor Progression by Enhancing Glycolysis via the Phosphatidylinositol 3-Kinase/Protein Kinase B Pathway in Oral Squamous Cell Carcinoma.
Long W; Gong X; Yang Y; Yang K
J Oral Maxillofac Surg; 2020 Oct; 78(10):1780.e1-1780.e14. PubMed ID: 32615095
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of TRIM31 suppresses proliferation and invasion of gallbladder cancer cells by down-regulating MMP2/9 through the PI3K/Akt signaling pathway.
Li H; Zhang Y; Hai J; Wang J; Zhao B; Du L; Geng X
Biomed Pharmacother; 2018 Jul; 103():1272-1278. PubMed ID: 29864908
[TBL] [Abstract][Full Text] [Related]
4. PSMC2 knockdown inhibits the progression of oral squamous cell carcinoma by promoting apoptosis via PI3K/Akt pathway.
Wang Z; Xiong H; Zuo Y; Hu S; Zhu C; Min A
Cell Cycle; 2022 Mar; 21(5):477-488. PubMed ID: 34979867
[TBL] [Abstract][Full Text] [Related]
5. PER1 suppresses glycolysis and cell proliferation in oral squamous cell carcinoma via the PER1/RACK1/PI3K signaling complex.
Gong X; Tang H; Yang K
Cell Death Dis; 2021 Mar; 12(3):276. PubMed ID: 33723221
[TBL] [Abstract][Full Text] [Related]
6. TRIM31 promotes proliferation, invasion and migration of glioma cells through Akt signaling pathway.
Shi G; Lv C; Yang Z; Qin T; Sun L; Pan P; Wang D
Neoplasma; 2019 Sep; 66(5):727-735. PubMed ID: 31129970
[TBL] [Abstract][Full Text] [Related]
7. CiRS-7 functions as a ceRNA of RAF-1/PIK3CD to promote metastatic progression of oral squamous cell carcinoma via MAPK/AKT signaling pathways.
Dou Z; Gao L; Ren W; Zhang H; Wang X; Li S; Zheng J; Kong X; Chi P; Zhi K
Exp Cell Res; 2020 Nov; 396(2):112290. PubMed ID: 32956704
[TBL] [Abstract][Full Text] [Related]
8. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.
Guo Y; Li Q; Zhao G; Zhang J; Yuan H; Feng T; Ou D; Gu R; Li S; Li K; Lin P
Cell Death Dis; 2021 Oct; 12(10):945. PubMed ID: 34650049
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of RABL3 suppresses the proliferation and invasion of oral squamous cell carcinoma through inactivating the FAK/AKT pathway.
Xu Z; Li H; Lin C; Zeng B; Chen Y; Luo Y
J Bioenerg Biomembr; 2021 Apr; 53(2):203-211. PubMed ID: 33438143
[TBL] [Abstract][Full Text] [Related]
10.
Tang KL; Tang HY; Du Y; Tian T; Xiong SJ
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31213575
[No Abstract] [Full Text] [Related]
11. TRIM32 promotes oral squamous cell carcinoma progression by enhancing FBP2 ubiquitination and degradation.
Yang X; Ma H; Zhang M; Wang R; Li X
Biochem Biophys Res Commun; 2023 Oct; 678():165-172. PubMed ID: 37640002
[TBL] [Abstract][Full Text] [Related]
12. ZNF677 inhibits oral squamous cell carcinoma growth and tumor stemness by regulating FOXO3a.
Zhang Z; Zhang Y; Hu X; Chen Y; Zhuang L; Zhang S
Hum Cell; 2023 Jul; 36(4):1464-1476. PubMed ID: 37129799
[TBL] [Abstract][Full Text] [Related]
13. As a Novel Tumor Suppressor, LHPP Promotes Apoptosis by Inhibiting the PI3K/AKT Signaling Pathway in Oral Squamous Cell Carcinoma.
Liu S; Gao W; Lu Y; Zhou Q; Su R; Hasegawa T; Du J; Li M
Int J Biol Sci; 2022; 18(2):491-506. PubMed ID: 35002505
[TBL] [Abstract][Full Text] [Related]
14. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
Chen M; Zhang J
J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
[TBL] [Abstract][Full Text] [Related]
15. TRIB3 promotes the growth of oral squamous cell carcinoma by regulating JNK/JUN-mediated aerobic glycolysis.
Meng Z; Wang Y; Wang X; Han X
Arch Oral Biol; 2024 Aug; 164():105977. PubMed ID: 38696945
[TBL] [Abstract][Full Text] [Related]
16. POLE2 Regulates Apoptosis of Oral Squamous Cell Carcinoma Cells through the PI3K/AKT Signaling Pathway.
Sun MY; Wang L; Shen ZY
Curr Med Sci; 2023 Dec; 43(6):1162-1172. PubMed ID: 38079056
[TBL] [Abstract][Full Text] [Related]
17. Abnormal downregulation of 10-formyltetrahydrofolate dehydrogenase promotes the progression of oral squamous cell carcinoma by activating PI3K/Akt/Rb pathway.
Qu Y; He Y; Ruan H; Qin L; Han Z
Cancer Med; 2023 Mar; 12(5):5781-5797. PubMed ID: 36336972
[TBL] [Abstract][Full Text] [Related]
18. FERMT1 knockdown inhibits oral squamous cell carcinoma cell epithelial-mesenchymal transition by inactivating the PI3K/AKT signaling pathway.
Wang X; Chen Q
BMC Oral Health; 2021 Nov; 21(1):598. PubMed ID: 34814915
[TBL] [Abstract][Full Text] [Related]
19. Spindle and kinetochore-associated complex 3 promotes cell growth via the PI3K/AKT/GSK3β and PI3K/AKT/FOXO1 pathways and is a potential prognostic biomarker for oral squamous cell carcinoma.
Xu H; Chen G; Niu Q; Song K; Feng Z; Han Z
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Nov; 134(5):599-614. PubMed ID: 36123287
[TBL] [Abstract][Full Text] [Related]
20. FSCN1 promotes proliferation, invasion and glycolysis via the IRF4/AKT signaling pathway in oral squamous cell carcinoma.
Li L; Chen L; Li Z; Huang S; Chen Y; Li Z; Chen W
BMC Oral Health; 2023 Jul; 23(1):519. PubMed ID: 37491232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
